Gene · 1612
Papers4,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The targeting of DAPK1 with miR-190a-3p promotes autophagy in trophoblast cells. | Mol Reprod Dev | 2024 | 38282318 | PubTator, text mining | PubMed |
| Rapamycin as a Potential Alternative Drug for Squamous Cell Gingiva Carcinoma (Ca9-22): A Focus on Cell Cycle, Apoptosis and Autophagy Genetic Profile. | Pharmaceuticals (Basel) | 2024 | 38276004 | PubTator, text mining | PubMed |
| Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells. | Cancers (Basel) | 2024 | 38275910 | PubTator, text mining | PubMed |
| Promoter DNA methylation patterns in oral, laryngeal and oropharyngeal anatomical regions are associated with tumor differentiation, nodal involvement and survival. | Oncol Lett | 2024 | 38268779 | PubTator, text mining | PubMed |
| Enhanced Sensitivity of A549 Cells to Doxorubicin with WS2 and WSe2 Nanosheets via the Induction of Autophagy. | Int J Mol Sci | 2024 | 38256235 | PubTator, text mining | PubMed |
| Aberrant DNA Methylation of NPTX2 as an Indicator of Malignant Behavior in Thymic Epithelial Tumors. | Cancers (Basel) | 2024 | 38254821 | PubTator, text mining | PubMed |
| DNA methylation landscape reveals GNAS as a decitabine-responsive marker in patients with acute myeloid leukemia. | Neoplasia | 2024 | 38245923 | PubTator, text mining | PubMed |
| Anoikis related genes may be novel markers associated with prognosis for ovarian cancer. | Sci Rep | 2024 | 38238592 | PubTator, text mining | PubMed |
| Anoikis-related signature identifies tumor microenvironment landscape and predicts prognosis and drug sensitivity in colorectal cancer. | J Cancer | 2024 | 38213716 | PubTator, text mining | PubMed |
| Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head/neck squamous cell carcinoma (HNSCC): A systematic review and network meta-analysis. | Jpn Dent Sci Rev | 2024 | 38204964 | PubTator, text mining | PubMed |
| Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease. | Transl Neurodegener | 2024 | 38195518 | PubTator, text mining | PubMed |
| Stabilization of Pin1 by USP34 promotes Ubc9 isomerization and protein sumoylation in glioma stem cells. | Nat Commun | 2024 | 38167292 | PubTator, text mining | PubMed |
| Identification of potential biological processes and key genes in diabetes-related stroke through weighted gene co-expression network analysis. | BMC Med Genomics | 2024 | 38166912 | PubTator, text mining | PubMed |
| BNIP3 and DAPK1 methylation in peripheral blood leucocytes are noninvasive biomarkers for gastric cancer. | Gene | 2024 | 38142898 | PubTator, text mining | PubMed |
| GSK-3β as a Potential Coordinator of Anabolic and Catabolic Pathways in Hepatitis C Virus Insulin Resistance. | Intervirology | 2024 | 38104537 | PubTator, text mining | PubMed |
| Unveiling the role of MGMT and DAPK hypermethylation in response to anti-EGFR agents: Molecular insights for advancing HNSCC treatment. | Head Neck | 2024 | 38095042 | PubTator, text mining | PubMed |
| Saliva as a potential non-invasive liquid biopsy for early and easy diagnosis/prognosis of head and neck cancer. | Transl Oncol | 2024 | 38042138 | PubTator, text mining | PubMed |
| Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer. | Transl Oncol | 2024 | 38042134 | PubTator, text mining | PubMed |
| Alzheimer's Disease and Cancer: Common Targets. | Mini Rev Med Chem | 2024 | 38037912 | PubTator, text mining | PubMed |
| Phosphorylation-driven aggregative proteins in neurodegenerative diseases: implications and therapeutics. | Neural Regen Res | 2024 | 37862191 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1612/papers?page=9